Literature DB >> 21424138

[The significance of bleeding disorders in patients with epistaxis].

T Taeumer1, A de Greiff, I Scharrer, K Papaspyrou, T Mewes, W Mann.   

Abstract

BACKGROUND: Epistaxis can have a variety of different local or systemic causes. It is the cardinal symptom of von Willebrand disease (VWD), the most frequent congenital bleeding disorder with a prevalence of approximately 1%. The usual routine coagulation screening tests (PT, APTT, platelet count) are not sufficient to diagnose VWD, factor XIII (FXIII)-deficiency or platelet dysfunction.
METHOD: A prospective study was conducted implementing enhanced coagulation screening for bleeding disorders in a total of 100 inpatients admitted for epistaxis.
RESULTS: A bleeding disorder was found in 13%. In eight patients VWD was diagnosed, in six patients FXIII-deficiency was found, and in one patient both.
CONCLUSION: The prevalence of bleeding disorders in patients with epistaxis is higher than in the general population. Epistaxis can be the primary symptom of chronic inflammatory disease or malignant disease. A thorough anamnesis is necessary and in cases of doubt additional testing for underlying disorders is recommended.

Entities:  

Mesh:

Year:  2011        PMID: 21424138     DOI: 10.1007/s00106-010-2245-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  18 in total

Review 1.  Factor XIII deficiency.

Authors:  R Anwar; K J Miloszewski
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

2.  Routine coagulation screening in the management of emergency admission for epistaxis--is it necessary?

Authors:  M A Thaha; E L Nilssen; S Holland; G Love; P S White
Journal:  J Laryngol Otol       Date:  2000-01       Impact factor: 1.469

3.  Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.

Authors:  Hannelore Haubelt; Christof Anders; Anette Vogt; Petra Hoerdt; Ulrich Theo Seyfert; Peter Hellstern
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

Review 4.  [Current aspects in epistaxis].

Authors:  B J Folz; M Kanne; J A Werner
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

5.  Epistaxis: a retrospective review of hospitalized patients.

Authors:  P A Pollice; M G Yoder
Journal:  Otolaryngol Head Neck Surg       Date:  1997-07       Impact factor: 5.591

Review 6.  Factor XIII deficiency.

Authors:  L Hsieh; D Nugent
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

7.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

8.  Bleeding manifestations in males with von Willebrand disease.

Authors:  O Ziv; M V Ragni
Journal:  Haemophilia       Date:  2004-03       Impact factor: 4.287

Review 9.  Epistaxis.

Authors:  L K Tan; K H Calhoun
Journal:  Med Clin North Am       Date:  1999-01       Impact factor: 5.456

Review 10.  Factor XIII: inherited and acquired deficiency.

Authors:  P G Board; M S Losowsky; K J Miloszewski
Journal:  Blood Rev       Date:  1993-12       Impact factor: 8.250

View more
  1 in total

1.  In Reply.

Authors:  Andreas Dietz; Martin Sorge; Rafael Beck; Antonius Schneider
Journal:  Dtsch Arztebl Int       Date:  2018-04-06       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.